ESR2 and colorectal carcinoma: The present data correlate with many earlier studies and emphasise the chemopreventive effects of E2 that could involve inhibition of CRC progression by ERβ-induced cell cycle arrest and apoptosis in malignant enterocytes (18, 20–23, 57).